A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody.

The selection of the appropriate excipient and the amount of excipient required to achieve a 2-year shelf-life is often done by using iso-osmotic concentrations of excipients such as sugars (e.g., 275 mM sucrose or trehalose) and salts. Excipients used for freeze-dried protein formulations are selected for their ability to prevent protein denaturation during the freeze-drying process as well as during storage. Using a model recombinant humanized monoclonal antibody (rhuMAb HER2), we assessed the impact of lyoprotectants, sucrose, and trehalose, alone or in combination with mannitol, on the storage stability at 40 degrees C. Molar ratios of sugar to protein were used, and the stability of the resulting lyophilized formulations was determined by measuring aggregation, deamidation, and oxidation of the reconstituted protein and by infrared (IR) spectroscopy (secondary structure) of the dried protein. A 360:1 molar ratio of lyoprotectant to protein was required for storage stability of the protein, and the sugar concentration was 3-4-fold below the iso-osmotic concentration typically used in formulations. Formulations with combinations of sucrose (20 mM) or trehalose (20 mM) and mannitol (40 mM) had comparable stability to those with sucrose or trehalose alone at 60 mM concentration. A formulation with 60 mM mannitol alone provided slightly less protection during storage than 60 mM sucrose or trehalose. The disaccharide/mannitol formulations also inhibited deamidation during storage to a greater extent than the lyoprotectant formulations alone. The reduction in aggregation and deamidation during storage correlated directly with inhibition of unfolding during lyophilization, as assessed by IR spectroscopy. Thus, it appears that the protein must be retained in its native-like state during freeze-drying to assure storage stability in the dried solid. Long-term studies (23-54 months) performed at 40 degrees C revealed that the appropriate molar ratio of sugar to protein stabilized against aggregation and deamidation for up to 33 months. Therefore, long-term storage at room temperature or above may be achieved by proper selection of the molar ratio and sugar mixture. Overall, a specific sugar/protein molar ratio was sufficient to provide storage stability of rhuMAb HER2.

[1]  J. Carpenter,et al.  Application of infrared spectroscopy to development of stable lyophilized protein formulations. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  M. Manning,et al.  Effect of Tween 20 on freeze-thawing- and agitation-induced aggregation of recombinant human factor XIII. , 1998, Journal of pharmaceutical sciences.

[3]  T. Arakawa,et al.  Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers. , 1993, Biophysical journal.

[4]  B. Kabakoff,et al.  Identification of multiple sources of charge heterogeneity in a recombinant antibody. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[5]  K. Nielsen Stability of freeze dried horseradish peroxidase conjugated monoclonal antibodies used in diagnostic serology. , 1995, Journal of immunoassay.

[6]  G. Amidon,et al.  Protein denaturation during freezing and thawing in phosphate buffer systems: monomeric and tetrameric beta-galactosidase. , 2000, Archives of biochemistry and biophysics.

[7]  K. Middleton,et al.  Optimization of storage stability of lyophilized actin using combinations of disaccharides and dextran. , 2000, Journal of pharmaceutical sciences.

[8]  R. Langer,et al.  Formulation and Delivery of Proteins and Peptides. Design and Development Strategies. , 1995 .

[9]  H Leuenberger,et al.  Formulations of sugars with amino acids or mannitol--influence of concentration ratio on the properties of the freeze-concentrate and the lyophilizate. , 1998, Pharmaceutical development and technology.

[10]  J L Cleland,et al.  The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.

[11]  S. Yoshioka,et al.  Effect of mannitol crystallinity on the stabilization of enzymes during freeze-drying. , 1994, Chemical & pharmaceutical bulletin.

[12]  J L Cleland,et al.  Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2. , 1997, Journal of pharmaceutical sciences.

[13]  D. Marshak,et al.  TECHNIQUES IN PROTEIN CHEMISTRY VII , 1996 .

[14]  R. Suryanarayanan,et al.  Characterization of phase transitions during freeze-drying by in situ X-ray powder diffractometry. , 1998, Pharmaceutical development and technology.

[15]  R. Artico,et al.  Use of subambient differential scanning calorimetry to monitor the frozen-state behavior of blends of excipients for freeze-drying. , 1997, PDA journal of pharmaceutical science and technology.

[16]  J. Carpenter,et al.  Protein formulation and lyophilization cycle design: prevention of damage due to freeze-concentration induced phase separation. , 1999, Biotechnology and bioengineering.

[17]  S J Prestrelski,et al.  Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. I. Enzyme activity and calorimetric studies. , 1993, Archives of biochemistry and biophysics.

[18]  Reed J. Harris,et al.  The application of tert-butylhydroperoxide oxidation to study sites of potential methionine oxidation in a recombinant antibody , 1996 .

[19]  H Leuenberger,et al.  Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage. , 1998, Pharmaceutical development and technology.

[20]  L. Presta,et al.  Humanization of an anti-p185HER2 antibody for human cancer therapy. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  B. Chang,et al.  Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding. , 1999, Archives of biochemistry and biophysics.

[22]  S. Frokjaer,et al.  Effects of additives on the stability of recombinant human factor XIII during freeze-drying and storage in the dried solid. , 1998, Archives of biochemistry and biophysics.